Silence Therapeutics plc
SLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $324,906 | $506,610 | $405,881 | $523,351 |
| - Cash | $121,330 | $54,031 | $54,816 | $73,537 |
| + Debt | $117 | $272 | $446 | $137 |
| Enterprise Value | $203,693 | $452,851 | $351,511 | $449,951 |
| Revenue | $43,258 | $25,375 | $21,655 | $12,415 |
| % Growth | 70.5% | 17.2% | 74.4% | – |
| Gross Profit | $31,448 | $15,057 | $8,192 | $4,959 |
| % Margin | 72.7% | 59.3% | 37.8% | 39.9% |
| EBITDA | -$48,989 | -$49,778 | -$60,444 | -$45,421 |
| % Margin | -113.2% | -196.2% | -279.1% | -365.9% |
| Net Income | -$45,309 | -$43,267 | -$50,334 | -$39,410 |
| % Margin | -104.7% | -170.5% | -232.4% | -317.4% |
| EPS Diluted | -2.37 | -3.48 | -3.81 | -1.36 |
| % Growth | 31.9% | 8.7% | -180.1% | – |
| Operating Cash Flow | -$67,640 | -$39,350 | -$57,044 | $9,186 |
| Capital Expenditures | -$211 | -$45 | -$545 | -$1,800 |
| Free Cash Flow | -$67,851 | -$39,395 | -$57,589 | $7,385 |